Correlation Between Mangalam Drugs and AXISCADES Technologies

Can any of the company-specific risk be diversified away by investing in both Mangalam Drugs and AXISCADES Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangalam Drugs and AXISCADES Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangalam Drugs And and AXISCADES Technologies Limited, you can compare the effects of market volatilities on Mangalam Drugs and AXISCADES Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of AXISCADES Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and AXISCADES Technologies.

Diversification Opportunities for Mangalam Drugs and AXISCADES Technologies

-0.56

Correlation Coefficient

Mangalam Drugs  AXISCADES Technologies

Excellent diversification

The 3 months correlation between Mangalam and AXISCADES is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and AXISCADES Technologies Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AXISCADES Technologies and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with AXISCADES Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AXISCADES Technologies has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and AXISCADES Technologies go up and down completely randomly.

Pair Corralation between Mangalam Drugs and AXISCADES Technologies

Assuming the 90 days trading horizon Mangalam Drugs And is expected to under-perform the AXISCADES Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Mangalam Drugs And is 1.17 times less risky than AXISCADES Technologies. The stock trades about -0.13 of its potential returns per unit of risk. The AXISCADES Technologies Limited is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  138,680  in AXISCADES Technologies Limited on July 15, 2025 and sell it today you would earn a total of  28,200  from holding AXISCADES Technologies Limited or generate 20.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Mangalam Drugs And  vs.  AXISCADES Technologies Limited

Mangalam Drugs And

Risk-Adjusted Performance

Weakest

Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in November 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

AXISCADES Technologies

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in AXISCADES Technologies Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, AXISCADES Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mangalam Drugs and AXISCADES Technologies

The main advantage of trading using opposite Mangalam Drugs and AXISCADES Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, AXISCADES Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AXISCADES Technologies will offset losses from the drop in AXISCADES Technologies' long position.

The idea behind Mangalam Drugs And and AXISCADES Technologies Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.